1.
Adelusi TI, Abdul-Hammed M, Ojo EM, Oyedele QK, Boyenle ID, Adedotun IO, et al. Molecular Docking Assessment of Clinically Approved Antiviral Drugs against Mpro, Spike Glycoprotein and Angiotensin Converting Enzyme-2 Revealed Probable Anti-SARS-CoV-2 Potential: doi.org/10.26538/tjnpr/v5i4.30. TJNPR [Internet]. 2021 Mar. 1 [cited 2024 Nov. 25];5(4):778-91. Available from: https://tjnpr.org/index.php/home/article/view/677